Health

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains inadequately controlled on current therapies These are the first global Phase 3 studies of a long-acting anti-TSLP antibody, marking a pivotal step as GB-0895 advances the pro...

2025-12-01 19:00 238

Lee's Pharm Supports Disaster Relief Efforts for Wang Fuk Court in Tai Po

HONG KONG, Dec. 1, 2025 /PRNewswire/ -- Lee's Pharmaceutical Holdings Limited (" Lee's Pharm" or the "Group", stock code: 0950.HK) expresses its deep condolences to the victims of the serious fire at Wang Fuk Court inTai Po, which caused multiple casualties and left many residents homeless and in ...

2025-12-01 18:46 337

CooperVision Opens Regional Service Centre in partnership with CEVA Logistics to Accelerate Asia Pacific Growth.

Driving faster delivery and broader portfolio access across the region. SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- CooperVision Asia Pacific, in collaboration with CEVA Logistics, has opened a new Regional Service Centre in Singapore, marking a significant milestone in both companies' commitment to ...

2025-12-01 17:10 553

Asia PGI and partners unveil preview of PathGen: new AI-powered outbreak intelligence tool

Asia-led, "sovereign-by-design" platform built for secure, decentralised pathogen intelligence-sharing across borders aims to break data silos and provide faster "time to actionable insight" of outbreaks, from detection to control measures being in place. SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- ...

2025-12-01 17:10 548

Medit recognized as the top brand in a global brand perception study by an external insights agency

Global sentiment analysis of 3,800 discussions from Reddit's r/Dentistry community highlights strong user recognition in software usability, workflow flexibility, and overall value. SEOUL, South Korea, Dec. 1, 2025 /PRNewswire/ -- Medit, a leading digital dentistry company, has been ranked as th...

2025-12-01 16:00 349

Hedia appoints new CEO: Rasmus Kofoed to succeed Lars Christian Lund

COPENHAGEN, Denmark, Dec. 1, 2025 /PRNewswire/ -- Danish diabetes‑tech company Hedia is implementing a leadership change effective1 December 2025, when Rasmus Kofoed will take over as Chief Executive Officer (CEO). He succeeds Lars Christian Lund, who after approximately 2 years in the role has d...

2025-12-01 16:00 322

The Wisdom Derived from the Great Migration: Hakka Medicine - The Unique "Medical Epic" of the Hakka People

HONG KONG, Dec. 1, 2025 /PRNewswire/ -- From November 23rd to 25th, the 7th World Hakka Conference was held in Meizhou,Guangdong. With the theme "Gathering Global Hakka Businesspeople to Foster High-Quality Development," the conference adhered to the principles of "openness, innovation, cooperati...

2025-12-01 15:26 398

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials

Securely connecting AI agents across multiple companies for rapid response to changing circumstances KAWASAKI, Japan, Dec. 1, 2025 /PRNewswire/ -- Fujitsu Limited today announced the development of a multi-AI agent collaboration technology...

2025-12-01 15:24 397

Oxford Instruments launches Imaris 11: boosting research productivity with clear, workflow-driven image analysis

LONDON, Dec. 1, 2025 /PRNewswire/ -- Oxford Instruments announces the release of Imaris 11, the latest generation of its industry-leading 3D/4D microscopy image visualisation and analysis software. The new version introduces an intuitive Workflow system, enhanced batch processing, and advanced to...

2025-12-01 09:00 635

MetaOptics Announces Strategic Share Placement to Accelerate Growth and Meet Rising Global Demand

SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) (" MetaOptics" or the "Company", and together with its subsidiaries, the "Group"), a leading-edge semiconductor optics company, announced that it is proposing to raiseS$4.85 million through a placement of 6,685,028 new ordinary...

2025-12-01 08:30 558

The Science of Longevity: Inside Prof. Mike Chan's Vision for Living Stronger, Smarter, and Longer

BANGKOK, Dec. 1, 2025 /PRNewswire/ -- Malaysia had a rare moment of reflection this year when former Prime Minister Tun Dr. Mahathir Mohamad turned 100. His milestone sparked public conversations about aging, vitality, and what it truly means to remain strong at any age.

2025-12-01 00:57 796

The Bioregenerative Sports Revolution: How Prof. Mike Chan Is Changing Athlete Recovery -- From Sabah to the Super Bowl

KOTA KINABALU, Malaysia, Dec. 1, 2025 /PRNewswire/ -- Big changes often start in small ways. For Sabah FC, a top Malaysian football club, it began with a simple agreement — a partnership with European Wellness, a medical group best known for anti-aging and precursor stem cell therapy.

2025-12-01 00:27 929

Perlis Royalty Join Prof. Mike Chan in Strengthening Malaysia's Fight Against Autism

KUALA LUMPUR, Malaysia, Nov. 30, 2025 /PRNewswire/ -- Malaysia's drive to modernize autism care received strong support today when the Raja Muda of Perlis, Tuanku Syed Faizuddin Putra Jamalullail, and his consort, Tuanku Dr. Hajah Lailatul Shahreen Akashah Khalil, attended the International Congr...

2025-12-01 00:07 827

Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

-  Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9-, 30-, and 60-fold higher than semaglutide, tirzepatide, and retatrutide in the oral SNAC formulation, respectively, in head-to...

2025-11-30 18:15 801

Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery

SHANGHAI, Nov. 30, 2025 /PRNewswire/ -- On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings inWang Fuk Court inTai Po, Hong Kong, causing severe casualties and drawing widespread public concern. In response, onNovember 28, Qiming Venture Partners mad...

2025-11-30 07:17 1218

ANKH Pain Relief Health Group Donates HK$1 Million to the Hong Kong Red Cross To Support Disaster Relief Efforts

HONG KONG, Nov. 29, 2025 /PRNewswire/ -- In response to the devastating No. 5 alarm fire at Wang Fuk Court,Tai Po, ANKH Pain Relief Health Group has donated HK$1 million to the Hong Kong Red Cross to support their "Tai Po Fire Emergency Appeal". The major blaze at Wang Fuk Court has caused serio...

2025-11-29 08:00 1839

HEISR's Kickstarter-Favorite 3-Sided Toothbrush Returns to the U.S. for Black Friday, Offering Faster, Deeper, and Gentler Daily Cleaning

LAS VEGAS, Nov. 28, 2025 /PRNewswire/ -- The 3-sided electric toothbrush that gained strong support on Kickstarter in 2023 is officially returning to the U.S. this Black Friday. As more users seek practical upgrades to their everyday routines, HEISR reintroduces its patented wrap-around design kn...

2025-11-28 23:15 1611

HZICC:Innovation hub: Hangzhou witness new voices and new ambitions

HANGZHOU, China, Nov. 28, 2025 /PRNewswire/ -- The remarkable achievements of past winners of Hangzhou's Innovation & Entrepreneurship Competition for Overseas Talents have set a powerful example, inspiring a new wave of international innovators to bring their projects toHangzhou. Among this yea...

2025-11-28 21:25 815

HZICC:Unlocked potential: why global innovators choose Hangzhou

HANGZHOU, China, Nov. 28, 2025 /PRNewswire/ -- Meng Jintao, winner of the 2024 Hangzhou's Innovation & Entrepreneurship Competition for Overseas Talents, exemplifies this journey. His project on "All-Iron Redox Flow Battery Technology"--dubbed a "giant movable power bank"--has already secured let...

2025-11-28 21:19 795

BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough

* Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyngeal carcinoma * The company enables seamless Europe–China tech transfer and faster biologics development through an integrated, end-to-end...

2025-11-28 21:00 622
12345 ... 873